Suppr超能文献

人工二尖瓣腱索:实验与临床经验

Artificial mitral valve chordae: experimental and clinical experience.

作者信息

Zussa C, Frater R W, Polesel E, Galloni M, Valfré C

机构信息

Division of Cardiac Surgery, Regional Hospital, Treviso, Italy.

出版信息

Ann Thorac Surg. 1990 Sep;50(3):367-73. doi: 10.1016/0003-4975(90)90476-m.

Abstract

Failure of mitral valve reconstructive procedures often may be ascribed to severe or progressive alterations of subvalvar apparatus. Expanded polytetrafluoroethylene sutures were used to replace anterior leaflet mitral valve chordae in 8 animals (hypertensive dogs and growing sheep). After the positive results obtained during a 13-month follow-up, 5-0 sutures of the same material were introduced in clinical practice to replace mitral valve chordae. Twelve patients had two to six anterior leaflet chordae replaced for degenerative or rheumatic disease. In 3 patients, the intraoperative result was not acceptable and a prosthetic valve was inserted during the same operation. One case of late failure has been recorded so far (18 months after the procedure), owing to rupture of a natural chorda shortened at operation. Since that event, we have implanted supportive artificial chordae in case of diffuse alteration of natural chordae. The remaining patients show satisfactory hemodynamic results, and no valve-related events have been recognized up to 30 months after operation. We suggest use of 5-0 polytetrafluoroethylene sutures in replacing anterior leaflet chordae in degenerative, rheumatic, and congenital mitral valve diseases.

摘要

二尖瓣重建手术失败往往可能归因于瓣下结构的严重或渐进性改变。在8只动物(高血压犬和生长中的绵羊)中使用膨体聚四氟乙烯缝线替代二尖瓣前叶腱索。在13个月的随访中取得阳性结果后,将相同材料的5-0缝线引入临床实践以替代二尖瓣腱索。12例患者因退行性或风湿性疾病接受了两到六根二尖瓣前叶腱索置换。3例患者术中结果不理想,在同一手术中植入了人工瓣膜。迄今为止记录到1例晚期失败病例(手术后18个月),原因是手术中缩短的天然腱索破裂。自该事件发生以来,对于天然腱索弥漫性改变的情况,我们植入了支撑性人工腱索。其余患者血流动力学结果令人满意,术后30个月内未发现与瓣膜相关的事件。我们建议在退行性、风湿性和先天性二尖瓣疾病中使用5-0聚四氟乙烯缝线替代二尖瓣前叶腱索。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验